Found: 32
Select item for more details and to access through your institution.
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 2, p. 855, doi. 10.1172/JCI67144
- By:
- Publication type:
- Article
Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
- Published in:
- Stem Cells, 2015, v. 33, n. 8, p. 2400, doi. 10.1002/stem.2053
- By:
- Publication type:
- Article
REST Regulates Oncogenic Properties of Glioblastoma Stem Cells.
- Published in:
- Stem Cells, 2012, v. 30, n. 3, p. 405, doi. 10.1002/stem.1020
- By:
- Publication type:
- Article
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097407
- By:
- Publication type:
- Article
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 3, p. 757, doi. 10.3171/2021.3.JNS203045
- By:
- Publication type:
- Article
412 Synergistic Targeting of Lysine-specific demethylase 1 (LSD1) and MAPK Signaling: A Mechanism-Guided Therapeutic Approach for Glioblastoma (GBM).
- Published in:
- 2024
- By:
- Publication type:
- Abstract
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1085, doi. 10.3390/cancers15041085
- By:
- Publication type:
- Article
immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1911, doi. 10.1093/neuonc/noab128
- By:
- Publication type:
- Article
REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 775, doi. 10.1093/neuonc/noz030
- By:
- Publication type:
- Article
TMOD-17. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY FOR GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi272, doi. 10.1093/neuonc/noy148.1129
- By:
- Publication type:
- Article
DDIS-10. ENGINEERED EXOSOMES FOR GLIOMA THERAPY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi71, doi. 10.1093/neuonc/noy148.289
- By:
- Publication type:
- Article
DDIS-07. MSC-DERIVED EXOSOMES AND microRNA IN GLIOMA THERAPY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi70, doi. 10.1093/neuonc/noy148.286
- By:
- Publication type:
- Article
EXTH-30. IN SITU AUTOVACCINATION MEDIATED BY ONCOLYTIC ADENOVIRUS DELTA-24-RGDOX INDUCES EFFICACIOUS IMMUNITY AGAINST METASTATIC MELANOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi91, doi. 10.1093/neuonc/noy148.379
- By:
- Publication type:
- Article
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 3, p. 380, doi. 10.1093/neuonc/nox152
- By:
- Publication type:
- Article
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 5, p. 660, doi. 10.1093/neuonc/now239
- By:
- Publication type:
- Article
Mechanisms of action of rapamycin in gliomas.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 1, p. 1, doi. 10.1215/S1152851704000420
- By:
- Publication type:
- Article
Evaluation of in vitro and in vivo efficacy of pharmacological lysine‐specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.0R249
- By:
- Publication type:
- Article
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 1, doi. 10.3389/fneur.2023.1112207
- By:
- Publication type:
- Article
Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153814
- By:
- Publication type:
- Article
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2621, doi. 10.3390/cells10102621
- By:
- Publication type:
- Article
Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes.
- Published in:
- Journal of Neuro-Oncology, 2009, v. 92, n. 3, p. 357
- By:
- Publication type:
- Article
REST overexpression in mice causes deficits in spontaneous locomotion.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-29441-3
- By:
- Publication type:
- Article
PDPN marks a subset of aggressive and radiationresistant glioblastoma cells.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.941657
- By:
- Publication type:
- Article
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 5, p. 826, doi. 10.1093/neuonc/noad257
- By:
- Publication type:
- Article
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 2, p. 236, doi. 10.1093/neuonc/noad199
- By:
- Publication type:
- Article
Development of a rabbit human glioblastoma model for testing of endovascular selective intra-arterial infusion (ESIA) of novel stem cell-based therapeutics.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 1, p. 127, doi. 10.1093/neuonc/noad152
- By:
- Publication type:
- Article
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.
- Published in:
- Journal of Neurosurgery, 2020, v. 133, n. 4, p. 1182, doi. 10.3171/2019.6.JNS19327
- By:
- Publication type:
- Article
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
- Published in:
- Journal of Neurosurgery, 2018, v. 129, n. 6, p. 1446, doi. 10.3171/2017.7.JNS17668
- By:
- Publication type:
- Article
Ionizing radiation augments glioma tropism of mesenchymal stem cells.
- Published in:
- Journal of Neurosurgery, 2018, v. 128, n. 1, p. 287, doi. 10.3171/2016.9.JNS16278
- By:
- Publication type:
- Article
Mir-21-Sox<sub>2</sub> Axis Delineates Glioblastoma Subtypes with Prognostic Impact.
- Published in:
- Journal of Neuroscience, 2015, v. 35, n. 45, p. 15097, doi. 10.1523/JNEUROSCI.1265-15.2015
- By:
- Publication type:
- Article